The Board granted a 60 percent disability rating for sarcoidosis with pulmonary fibrosis and hilar adenopathy since November 19, 2004. The Veteran's sarcoidosis has manifested by pulmonary involvement requiring systemic high dose (therapeutic) corticosteroids for control.
The deciding factor: The Veteran's sarcoidosis with pulmonary fibrosis and hilar adenopathy required systemic high-dose corticosteroids since November 19, 2004.
- Claimed conditions
- sarcoidosis with pulmonary fibrosis and hilar adenopathy, traumatic arthritis, L4-L5, disc herniation, and L3 radiculopathy
- How they argued it
- Not specified
- Exposure basis
- None
- Rating assigned
- 60%
- Decision date
- August 30, 2010
- Citation
- 1032650
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 1032650.
What this means for you
A grant means the Board agreed the veteran was entitled to the benefit. Decisions like this show the kind of evidence and arguments that tend to succeed for claims like it.
What you can do next
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.